MedNet is proud to announce its inclusion on the INC 5000 list of fastest growing private companies for the second straight year.
MedNet Included in INC 5000 List
MedNet is proud to announce its inclusion on the INC 5000 list of fastest growing private companies for the second straight year. "We're both proud of our results and humbled by our good fortune and the dedication of our staff," said Rob Robertson President & CEO, "It appears our long term strategy of planned growth is bearing fruit. Ranking at number 36 in the Minneapolis-St Paul-Bloomingtoon-MN-WI region as a whole is very gratifying".
MedNet, a leading provider of eClinical Solutions, is headquatered in Minneapolis Minnesota, and counts Genentech, Teva Pharmaceuticals, AstraZeneca, ImClone, Medtronic and many others amongst its customer list for Studies of all phases conducted in over 40 countries. MedNet's corporate website is www.mednetstudy.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.